deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01698879

Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment

Treatment of de Novo Acute Myeloid Leukemia With the Combination of Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin (Mylotarg ®), Associated or Not Priming With G-CSF. Prospective Study of Efficacy and Toxicity

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

Conditions Novo Acute Myeloid Leukemia
Interventions Mylotarg
Updated 8 times since 2017 Last updated: Jan 26, 2021 Started: Oct 31, 2009 Primary completion: Sep 14, 2016 Completion: Sep 26, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Novo Acute Myeloid Leukemia and is currently completed. Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotActive Not Recruiting~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotUnknown Status~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotUnknown Status~Feb 2021 – ~Jul 2024 · 41 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Feb 2021 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

  5. Jan 2021 — Feb 2021 [monthly]

    Unknown Status PHASE2

▶ Show 3 earlier versions

  1. Sep 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  2. Jun 2018 — Sep 2018 [monthly]

    Active Not Recruiting PHASE2

  3. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Data source: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations